This change was inversely correlated with systemic IR levels, indicating that apelin may be beneficial for decreasing myocardial energy metabolism disorders in DCM via enhancing insulin sensitivity and promoting glucose metabolism [77]. The gene discussed is APLN; the disease is familial dilated cardiomyopathy.